Schade – dieser Artikel ist leider ausverkauft. Sobald wir wissen, ob und wann der Artikel wieder verfügbar ist, informieren wir Sie an dieser Stelle.
- Gebundenes Buch
- Merkliste
- Auf die Merkliste
- Bewerten Bewerten
- Teilen
- Produkt teilen
- Produkterinnerung
- Produkterinnerung
This new, thoroughly revised fifth edition of Child and Adolescent Psychiatry for the Specialty Board Review offers a comprehensive study guide of child psychiatry.
Andere Kunden interessierten sich auch für
- Disruptive Behavior Disorders74,99 €
- Kerstin KlappsteinTraumatisierte Kinder im Alltag feinfühlig unterstützen14,99 €
- Kasia KozlowskaFunctional Somatic Symptoms in Children and Adolescents30,99 €
- Child and Adolescent Psychiatry74,99 €
- Verhaltenstherapiemanual: Kinder und Jugendliche44,99 €
- Cynthia de Freitas MeloApplied Behaviour Analysis and Autism Spectrum Disorder23,99 €
- Psychopathology in Adolescents and Adults with Autism Spectrum Disorders85,99 €
-
-
-
This new, thoroughly revised fifth edition of Child and Adolescent Psychiatry for the Specialty Board Review offers a comprehensive study guide of child psychiatry.
Produktdetails
- Produktdetails
- Verlag: Taylor & Francis Ltd
- Seitenzahl: 206
- Erscheinungstermin: 8. Dezember 2023
- Englisch
- Abmessung: 280mm x 210mm
- Gewicht: 540g
- ISBN-13: 9781032312576
- ISBN-10: 1032312572
- Artikelnr.: 68710707
- Herstellerkennzeichnung
- Produktsicherheitsverantwortliche/r
- Europaallee 1
- 36244 Bad Hersfeld
- gpsr@libri.de
- Verlag: Taylor & Francis Ltd
- Seitenzahl: 206
- Erscheinungstermin: 8. Dezember 2023
- Englisch
- Abmessung: 280mm x 210mm
- Gewicht: 540g
- ISBN-13: 9781032312576
- ISBN-10: 1032312572
- Artikelnr.: 68710707
- Herstellerkennzeichnung
- Produktsicherheitsverantwortliche/r
- Europaallee 1
- 36244 Bad Hersfeld
- gpsr@libri.de
Caitlin R. Costello, MD, is an Associate Clinical Professor in the Department of Psychiatry and Behavioral Sciences, Division of Child and Adolescent Psychiatry, at the University of California, San Francisco, USA. She is the training director of the child and adolescent psychiatry fellowship program and the medical director of child and adolescent outpatient services at Langley Porter Psychiatric Hospital and Clinics. Her interests include medical education, curriculum development, obsessive-compulsive and tic disorders, the interface between psychiatry and the legal system, and juvenile justice. Lauren T. Schumacher, MD, is an Assistant Clinical Professor in the Department of Psychiatry and Behavioral Sciences, Division of Child and Adolescent Psychiatry, at the University of California, San Francisco, USA. She specializes in child and adolescent psychiatry with a particular interest in attention-deficit/hyperactivity disorder (ADHD) and anxiety disorders. She has presented at national conferences and is the author of multiple book chapters on pharmacological treatment of ADHD. She is also active in child and adolescent psychiatry fellowship training and medical student education.
Acknowledgement
Introduction
References
Part I: Multiple-Choice Questions
1 Normal Growth and Development
2 Neurodevelopmental Disorders
3 Schizophrenia and Other Psychotic Disorders
4 Bipolar and Related Disorders and Depressive Disorders
5 Disruptive, Impulse-Control, and Conduct Disorders
6 Anxiety Disorders, Obsessive-Compulsive and Related Disorders, Trauma-
and Stressor-Related Disorders, and Dissociative Disorders
7 Feeding and Eating Disorders, Elimination Disorders, and Obesity
8 Somatic Symptoms and Related Disorders and Sleep-Wake Disorders
9 Substance-Related and Addictive Disorders
10 Special Issues (Diverse Populations, Medically Ill Children, Suicide,
and Abuse)
11 Psychological Testing and Rating Scales
12 Psychopharmacology and Medication-Induced Movement Disorders and Other
Adverse Effects of Medication
13 Psychotherapies
14 Treatment Settings
15 Special Topics (Consultation, Forensics, and Public Health)
16 Research Design, Statistics, and Technologies
Part II: Clinical Cases
17 Case Histories, Clinical Assessment, Differential Diagnosis,
Formulation, and Treatment Planning
Introduction
References
Part I: Multiple-Choice Questions
1 Normal Growth and Development
2 Neurodevelopmental Disorders
3 Schizophrenia and Other Psychotic Disorders
4 Bipolar and Related Disorders and Depressive Disorders
5 Disruptive, Impulse-Control, and Conduct Disorders
6 Anxiety Disorders, Obsessive-Compulsive and Related Disorders, Trauma-
and Stressor-Related Disorders, and Dissociative Disorders
7 Feeding and Eating Disorders, Elimination Disorders, and Obesity
8 Somatic Symptoms and Related Disorders and Sleep-Wake Disorders
9 Substance-Related and Addictive Disorders
10 Special Issues (Diverse Populations, Medically Ill Children, Suicide,
and Abuse)
11 Psychological Testing and Rating Scales
12 Psychopharmacology and Medication-Induced Movement Disorders and Other
Adverse Effects of Medication
13 Psychotherapies
14 Treatment Settings
15 Special Topics (Consultation, Forensics, and Public Health)
16 Research Design, Statistics, and Technologies
Part II: Clinical Cases
17 Case Histories, Clinical Assessment, Differential Diagnosis,
Formulation, and Treatment Planning
Acknowledgement
Introduction
References
Part I: Multiple-Choice Questions
1 Normal Growth and Development
2 Neurodevelopmental Disorders
3 Schizophrenia and Other Psychotic Disorders
4 Bipolar and Related Disorders and Depressive Disorders
5 Disruptive, Impulse-Control, and Conduct Disorders
6 Anxiety Disorders, Obsessive-Compulsive and Related Disorders, Trauma- and Stressor-Related Disorders, and Dissociative Disorders
7 Feeding and Eating Disorders, Elimination Disorders, and Obesity
8 Somatic Symptoms and Related Disorders and Sleep-Wake Disorders
9 Substance-Related and Addictive Disorders
10 Special Issues (Diverse Populations, Medically Ill Children, Suicide, and Abuse)
11 Psychological Testing and Rating Scales
12 Psychopharmacology and Medication-Induced Movement Disorders and Other Adverse Effects of Medication
13 Psychotherapies
14 Treatment Settings
15 Special Topics (Consultation, Forensics, and Public Health)
16 Research Design, Statistics, and Technologies
Part II: Clinical Cases
17 Case Histories, Clinical Assessment, Differential Diagnosis, Formulation, and Treatment Planning
Introduction
References
Part I: Multiple-Choice Questions
1 Normal Growth and Development
2 Neurodevelopmental Disorders
3 Schizophrenia and Other Psychotic Disorders
4 Bipolar and Related Disorders and Depressive Disorders
5 Disruptive, Impulse-Control, and Conduct Disorders
6 Anxiety Disorders, Obsessive-Compulsive and Related Disorders, Trauma- and Stressor-Related Disorders, and Dissociative Disorders
7 Feeding and Eating Disorders, Elimination Disorders, and Obesity
8 Somatic Symptoms and Related Disorders and Sleep-Wake Disorders
9 Substance-Related and Addictive Disorders
10 Special Issues (Diverse Populations, Medically Ill Children, Suicide, and Abuse)
11 Psychological Testing and Rating Scales
12 Psychopharmacology and Medication-Induced Movement Disorders and Other Adverse Effects of Medication
13 Psychotherapies
14 Treatment Settings
15 Special Topics (Consultation, Forensics, and Public Health)
16 Research Design, Statistics, and Technologies
Part II: Clinical Cases
17 Case Histories, Clinical Assessment, Differential Diagnosis, Formulation, and Treatment Planning
Acknowledgement
Introduction
References
Part I: Multiple-Choice Questions
1 Normal Growth and Development
2 Neurodevelopmental Disorders
3 Schizophrenia and Other Psychotic Disorders
4 Bipolar and Related Disorders and Depressive Disorders
5 Disruptive, Impulse-Control, and Conduct Disorders
6 Anxiety Disorders, Obsessive-Compulsive and Related Disorders, Trauma-
and Stressor-Related Disorders, and Dissociative Disorders
7 Feeding and Eating Disorders, Elimination Disorders, and Obesity
8 Somatic Symptoms and Related Disorders and Sleep-Wake Disorders
9 Substance-Related and Addictive Disorders
10 Special Issues (Diverse Populations, Medically Ill Children, Suicide,
and Abuse)
11 Psychological Testing and Rating Scales
12 Psychopharmacology and Medication-Induced Movement Disorders and Other
Adverse Effects of Medication
13 Psychotherapies
14 Treatment Settings
15 Special Topics (Consultation, Forensics, and Public Health)
16 Research Design, Statistics, and Technologies
Part II: Clinical Cases
17 Case Histories, Clinical Assessment, Differential Diagnosis,
Formulation, and Treatment Planning
Introduction
References
Part I: Multiple-Choice Questions
1 Normal Growth and Development
2 Neurodevelopmental Disorders
3 Schizophrenia and Other Psychotic Disorders
4 Bipolar and Related Disorders and Depressive Disorders
5 Disruptive, Impulse-Control, and Conduct Disorders
6 Anxiety Disorders, Obsessive-Compulsive and Related Disorders, Trauma-
and Stressor-Related Disorders, and Dissociative Disorders
7 Feeding and Eating Disorders, Elimination Disorders, and Obesity
8 Somatic Symptoms and Related Disorders and Sleep-Wake Disorders
9 Substance-Related and Addictive Disorders
10 Special Issues (Diverse Populations, Medically Ill Children, Suicide,
and Abuse)
11 Psychological Testing and Rating Scales
12 Psychopharmacology and Medication-Induced Movement Disorders and Other
Adverse Effects of Medication
13 Psychotherapies
14 Treatment Settings
15 Special Topics (Consultation, Forensics, and Public Health)
16 Research Design, Statistics, and Technologies
Part II: Clinical Cases
17 Case Histories, Clinical Assessment, Differential Diagnosis,
Formulation, and Treatment Planning
Acknowledgement
Introduction
References
Part I: Multiple-Choice Questions
1 Normal Growth and Development
2 Neurodevelopmental Disorders
3 Schizophrenia and Other Psychotic Disorders
4 Bipolar and Related Disorders and Depressive Disorders
5 Disruptive, Impulse-Control, and Conduct Disorders
6 Anxiety Disorders, Obsessive-Compulsive and Related Disorders, Trauma- and Stressor-Related Disorders, and Dissociative Disorders
7 Feeding and Eating Disorders, Elimination Disorders, and Obesity
8 Somatic Symptoms and Related Disorders and Sleep-Wake Disorders
9 Substance-Related and Addictive Disorders
10 Special Issues (Diverse Populations, Medically Ill Children, Suicide, and Abuse)
11 Psychological Testing and Rating Scales
12 Psychopharmacology and Medication-Induced Movement Disorders and Other Adverse Effects of Medication
13 Psychotherapies
14 Treatment Settings
15 Special Topics (Consultation, Forensics, and Public Health)
16 Research Design, Statistics, and Technologies
Part II: Clinical Cases
17 Case Histories, Clinical Assessment, Differential Diagnosis, Formulation, and Treatment Planning
Introduction
References
Part I: Multiple-Choice Questions
1 Normal Growth and Development
2 Neurodevelopmental Disorders
3 Schizophrenia and Other Psychotic Disorders
4 Bipolar and Related Disorders and Depressive Disorders
5 Disruptive, Impulse-Control, and Conduct Disorders
6 Anxiety Disorders, Obsessive-Compulsive and Related Disorders, Trauma- and Stressor-Related Disorders, and Dissociative Disorders
7 Feeding and Eating Disorders, Elimination Disorders, and Obesity
8 Somatic Symptoms and Related Disorders and Sleep-Wake Disorders
9 Substance-Related and Addictive Disorders
10 Special Issues (Diverse Populations, Medically Ill Children, Suicide, and Abuse)
11 Psychological Testing and Rating Scales
12 Psychopharmacology and Medication-Induced Movement Disorders and Other Adverse Effects of Medication
13 Psychotherapies
14 Treatment Settings
15 Special Topics (Consultation, Forensics, and Public Health)
16 Research Design, Statistics, and Technologies
Part II: Clinical Cases
17 Case Histories, Clinical Assessment, Differential Diagnosis, Formulation, and Treatment Planning